Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease

American Journal of Cardiology

Volumn 115, Issue 3, 2015, Pages 316-322

  Allen LaPointe, Nancy M ^a   Dai, Dadi ^a   Thomas, Laine ^a   Piccini, Jonathan P ^a   Peterson, Eric D ^a   Al Khatib, Sana M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; DRONEDARONE; FLECAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

ANTICOAGULANT THERAPY; ARTICLE; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; COHORT ANALYSIS; DRUG SUBSTITUTION; FACTUAL DATABASE; LONGITUDINAL STUDY; MIDDLE AGED; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; DATABASES, FACTUAL; DRUG SUBSTITUTION; FEMALE; FLECAINIDE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPAFENONE; SOTALOL;

EID: 84920747994     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.11.005     Document Type: Article

References (21)

1. G.V. Naccarelli, H. Varker, J. Lin, and K.L. Schulman Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 2009 1534 1539
2. G.V. Naccarelli, S.S. Johnston, M. Dalal, J. Lin, and P.P. Patel Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter Am J Cardiol 109 2012 543 549
3. M.R. Reynolds, C.L. Gunnarsson, T.D. Hunter, J.A. Ladapo, J.L. March, M. Zhang, and S.C. Hao Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis Circ Cardiovasc Qual Outcomes 5 2012 171 181
4. N.M. Allen LaPointe, Y. Lokhnygina, G.D. Sanders, E.D. Peterson, and S.M. Al-Khatib Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation Am Heart J 166 2013 871 878
5. R. Ionescu-Ittu, M. Abrahamowicz, C.A. Jackevicius, V. Essebag, M.J. Eisenberg, W. Wynant, H. Richard, and L. Pilote Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation Arch Intern Med 172 2012 997 1004
6. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J.C. Luthi, L.D. Saunders, C.A. Beck, T.E. Feasby, and W.A. Ghali Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139
7. CredibleMeds® Web site. Available at: https://www.crediblemeds.org/index.php. Accessed on July 16, 2014.
8. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, G.N. Kay, J.Y. Le Huezey, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, L.S. Wann, S.C. Smith Jr., S.G. Priori, N.A. Estes III, M.D. Ezekowitz, W.M. Jackman, C.T. January, J.E. Lowe, R.L. Page, D.J. Slotwiner, W.G. Stevenson, C.M. Tracy, A.K. Jacobs, J.L. Anderson, N. Albert, C.E. Buller, M.A. Creager, S.M. Ettinger, R.A. Guyton, J.L. Halperin, J.S. Hochman, F.G. Kushner, E.M. Ohman, W.G. Stevenson, L.G. Tarkington, C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 e269 e367
9. C.T. January, L.S. Wann, J.S. Alpert, H. Calkins, J.C. Cleveland Jr., J.E. Cigarroa, J.B. Conti, P.T. Ellinor, M.D. Ezekowitz, M.E. Field, K.T. Murray, R.L. Sacco, W.G. Stevenson, P.J. Tchou, C.M. Tracy, and C.W. Yancy 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the heart rhythm society J Am Coll Cardiol 64 2014 e1 e76
10. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, J.L. Halperin, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, J.L. Zamorano American College of Cardiology/American Heart Association Task Force on Practice Guidelines European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
11. S.M. Al-Khatib, N.M. LaPointe, L.H. Curtis, J.M. Kramer, J. Swann, P. Honig, and R.M. Califf Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000 Am J Cardiol 91 2003 91 94
12. M. Alam, S.J. Bandeali, S.A. Shahzad, and N. Lakkis Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry Expert Rev Cardiovasc Ther 10 2012 283 291
13. N.M. Allen LaPointe, L. Governale, J. Watkins, J. Mulgund, and K.J. Anstrom Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation Am Heart J 154 2007 893 898
14. J.G. Andrade, S.J. Connolly, P. Dorian, M. Green, K.H. Humphries, G.J. Klein, R. Sheldon, M. Talajic, and C.R. Kerr Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II) Heart Rhythm 7 2010 1171 1177
15. M.C. Fang, R.S. Stafford, J.N. Ruskin, and D.E. Singer National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 2004 55 60
16. J.A. Reiffel, P.R. Kowey, R. Myerburg, G.V. Naccarelli, D.L. Packer, C.M. Pratt, M.J. Reiter, A.L. Waldo AFFECTS Scientific Advisory Committee and Investigators Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry) Am J Cardiol 105 2010 1122 1129
17. N.M. LaPointe, C.A. Pamer, and J.M. Kramer New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance Pharmacotherapy 23 2003 1316 1321
18. C. Piccinni, E. Raschi, E. Poluzzi, A. Puccini, T. Cars, B. Wettermark, I. Diemberger, G. Boriani, and F. De Ponti Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden Eur J Clin Pharmacol 69 2013 715 720
19. S.M. Said, H.D. Esperer, K. Kluba, C. Genz, A.K. Wiedemann, H. Boenigk, J. Herold, A. Schmeisser, and R.C. Braun-Dullaeus Efficacy and safety profile of dronedarone in clinical practice. Results of the Magdeburg Dronedarone Registry (MADRE study) Int J Cardiol 167 2013 2600 2604
20. M.H. Kim, P.J. Smith, M. Jhaveri, J. Lin, and D. Klingman One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis Clin Ther 33 2011 1668 1681.e1
21. L. Friberg Safety of dronedarone in routine clinical care J Am Coll Cardiol 63 2014 2376 2384